This application seeks continuing funding for the Cancer Center Support Grant (CCSG) of the University of Chicago Cancer Research (UCCRC), now in its thirteenth year of operation. Since its establishment in 1973, the UCCRC has built or renovated 50,000 square feet and submitted 18 program grants which were approved and funded. In the period 1973-1989, over $39 million National Cancer Institute (NCI) awards for programs and building/renovation will have been made; during the same period, institutional commitment will be over $30 million. Current (10/31/85) annual sponsored programs in cancer research and training total $12.7 million with $10.7 million from NCI and other federal agencies. Over 90 members participate in four program areas: Viral Oncology, Cancer Biology and Carcinogenesis, Cancer Immunology, Clinical-Laboratory Cancer Research. There are four approved program grants: Viral Oncology Program Grant, Etiology of Treatment-Induced Secondary Leukemia Program Grant, Immunity and Cancer Program Grant, and Clinical-Laboratory Studies in Gynecologic Cancer Program Grant. A renovation program is currently under way which will permit major recruitment in basic science as well as in clinical cancer research areas. The funds sought in this application will support (1) the Professional Personnel consisting of the Director and Deputy Director, (2) The Administrative Office of the UCCRC, (3) the Planning and Evaluation functions, (4) the Viral Oncology Core Facility, (5) the Erman Core Laboratory in Cancer Biology, (6) the High Resolution NMR Spectroscopy and Mass Spectrometry Cancer Research Facility, (7) the Biostatistical and Data Management Core Facility, (8) the Oligopeptide Synthesis Core Facility, (9) The Animal Barrier Core Facility, and (10) New Investigators.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA014599-18
Application #
3101443
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-02-01
Project End
1992-07-31
Budget Start
1991-02-01
Budget End
1992-07-31
Support Year
18
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Chicago
Department
Type
Schools of Medicine
DUNS #
225410919
City
Chicago
State
IL
Country
United States
Zip Code
60637
Luke, Jason J; Lemons, Jeffrey M; Karrison, Theodore G et al. (2018) Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol 36:1611-1618
Wang, Amy Y; Weiner, Howard; Green, Margaret et al. (2018) A phase I study of selinexor in combination with high-dose cytarabine and mitoxantrone for remission induction in patients with acute myeloid leukemia. J Hematol Oncol 11:4
Sample, Ashley; He, Yu-Ying (2018) Mechanisms and prevention of UV-induced melanoma. Photodermatol Photoimmunol Photomed 34:13-24
Jeong, Choongwon; Witonsky, David B; Basnyat, Buddha et al. (2018) Detecting past and ongoing natural selection among ethnically Tibetan women at high altitude in Nepal. PLoS Genet 14:e1007650
Wang, Xin; Wu, Xingye; Zhang, Zhonglin et al. (2018) Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway. Sci Rep 8:17914
Brown, Hailey M; Biering, Scott B; Zhu, Allen et al. (2018) Demarcation of Viral Shelters Results in Destruction by Membranolytic GTPases: Antiviral Function of Autophagy Proteins and Interferon-Inducible GTPases. Bioessays 40:e1700231
Karrison, Theodore; Kocherginsky, Masha (2018) Restricted mean survival time: Does covariate adjustment improve precision in randomized clinical trials? Clin Trials 15:178-188
An, Ningfei; Khan, Saira; Imgruet, Molly K et al. (2018) Gene dosage effect of CUX1 in a murine model disrupts HSC homeostasis and controls the severity and mortality of MDS. Blood 131:2682-2697
Trujillo, Jonathan A; Sweis, Randy F; Bao, Riyue et al. (2018) T Cell-Inflamed versus Non-T Cell-Inflamed Tumors: A Conceptual Framework for Cancer Immunotherapy Drug Development and Combination Therapy Selection. Cancer Immunol Res 6:990-1000
Zeng, Zongyue; Huang, Bo; Huang, Shifeng et al. (2018) The development of a sensitive fluorescent protein-based transcript reporter for high throughput screening of negative modulators of lncRNAs. Genes Dis 5:62-74

Showing the most recent 10 out of 668 publications